Sciclone Pharmaceut (SCLN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 25,208 | 21,689 | 13,774 | 4,134 | 10,964 |
| Depreciation Amortization | 852 | 652 | 431 | 207 | 860 |
| Income taxes - deferred | -321 | N/A | N/A | N/A | 191 |
| Accounts receivable | -3,276 | 3,307 | 1,432 | 7,516 | -3,999 |
| Accounts payable and accrued liabilities | -5,485 | -5,365 | -5,858 | -4,189 | -134 |
| Other Working Capital | -3,720 | 497 | -5,659 | -1,121 | -7,286 |
| Other Operating Activity | 14,351 | 5,674 | 6,491 | -2,430 | 8,906 |
| Operating Cash Flow | $27,609 | $26,454 | $10,611 | $4,117 | $9,502 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,452 | -1,065 | -471 | -111 | -324 |
| Sale Of Investment | N/A | N/A | N/A | N/A | 379 |
| Other Investing Activity | -4,751 | -2,501 | 0 | 0 | 0 |
| Investing Cash Flow | $-6,203 | $-3,566 | $-471 | $-111 | $55 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 2,196 |
| Debt Repayment | -1,620 | -1,619 | -1,616 | N/A | -2,035 |
| Common Stock Issued | 5,214 | 3,989 | 1,278 | 248 | 1,705 |
| Common Stock Repurchased | -24,400 | -14,179 | -8,590 | -2,569 | -12,519 |
| Other Financing Activity | 0 | 0 | 0 | 0 | 2,300 |
| Financing Cash Flow | $-20,806 | $-11,809 | $-8,928 | $-2,321 | $-8,353 |
| Exchange Rate Effect | -175 | -51 | -27 | -18 | 371 |
| Beginning Cash Position | 85,803 | 85,803 | 85,803 | 85,803 | 84,228 |
| End Cash Position | 86,228 | 96,831 | 86,988 | 87,470 | 85,803 |
| Net Cash Flow | $425 | $11,028 | $1,185 | $1,667 | $1,575 |
| Free Cash Flow | |||||
| Operating Cash Flow | 27,609 | 26,454 | 10,611 | 4,117 | 9,502 |
| Capital Expenditure | -1,452 | -1,065 | -471 | -111 | -324 |
| Free Cash Flow | 26,157 | 25,389 | 10,140 | 4,006 | 9,178 |